Temperance Rowell delves into the flavored world of e-cigarettes to investigate the long-term effects of a new trend.
The American Society of Hematology fills gap in decreased federal funding, supports 13 blood research projects.
The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.
New study in Diabetes Care suggests new delayed-release metformin could help 40 percent of type 2 diabetes patients that currently can’t take metformin.
UNC’s part in the study is led by Dr. Cynthia M. Bulik, Distinguished Professor of Eating Disorders in the Department of Psychiatry in the School of Medicine, a Professor of Nutrition in the Gillings School of Global Public Health, and Founding Director of the UNC Center of Excellence for Eating Disorders.
In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.
James Bear, PhD, uncovers the intricate mechanisms that allow certain cells to move, discoveries with implications for cancer metastasis.
A new study from UNC researchers in the department of genetics identifies a microRNA molecule (miR-29) that controls the levels of cholesterol and fat in the bloodstream by regulating the amount of cholesterol and fat production in the liver. The study is published in Nature's open access journal, Scientific Reports.
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
The research shows the precise cellular mechanisms that could increase risk for the disorder and how an existing drug might help thousands of people with autism.
Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner
These findings demonstrate that antiretroviral therapy, when taken until viral suppression is achieved and sustained, is a highly effective, durable intervention for HIV prevention.
The labs of Jean Cook, PhD, and Jeremy Purvis, PhD, will develop the first-ever interactive molecular model of a crucial cellular process that controls healthy growth and diseases such as cancer.
UNC’s Brian Strahl, PhD, and Van Andel Research Institute’s Scott Rothbart, PhD, create a robust online interactive database to address science’s ‘antibody crisis’.
Noninvasive prenatal screening tests may detect underlying maternal conditions, including cancer, in the mother, according to a study published July 13 in the Journal of the American Medical Association on which Dr. Neeta Vora, a clinical geneticist and assistant professor of maternal-fetal medicine at UNC's Department of Obstetrics and Gynecology, is co-author.
A survey of college-aged women finds that those with the strongest emotional connection to Facebook are less likely to struggle with risky dieting behaviors compared to their peers.
The finding published in PLoS One suggests that elevated oxidized LDL cholesterol and fructosamine – a measure of glycated proteins in blood sugar – are signposts for the development of severe coronary disease, especially in females.
Their article, published in The New England Journal of Medicine, explores the pros and cons of five different interventional approaches to treating gallbladder disease – a condition that affects more than 25 million Americans.
UNC OB-GYN's Division of Maternal-Fetal Medicine has unveiled a free, web-based calculator to help providers better counsel patients on the benefits and risks of the four most common screening tools for fetal genetic abnormalities available commercially in the U.S.
A UNC core facility churns out radioactive agents to investigate the subcellular activity that drives disease.
Clinical trials studying kidney disease usually use end-stage kidney disease as the primary outcome, or end point, of a study. For many kidney diseases end-stage kidney disease may not occur for several years, sometimes 10 or more. A new paper examines surrogate endpoints. Patrick Nachman, MD, of the UNC Kidney Center, is one of the paper's authors.